Detalles de la búsqueda
1.
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.
Int J Cancer
; 151(7): 1047-1058, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579975
2.
Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
Int J Cancer
; 148(2): 320-328, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663316
3.
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Int J Cancer
; 147(7): 1864-1873, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32170961
4.
Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
Int J Cancer
; 147(1): 9-13, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970768
5.
Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study.
Breast Cancer Res Treat
; 177(3): 761-765, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31250357
6.
Impacts of human papillomavirus vaccination for different populations: A modeling study.
Int J Cancer
; 143(5): 1086-1092, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603224
7.
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs.
Int J Cancer
; 143(4): 735-745, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29341110
8.
Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
Int J Cancer
; 142(1): 44-56, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28940326
9.
Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more.
Int J Cancer
; 143(2): 333-342, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29453769
10.
MicroRNAs as markers of progression in cervical cancer: a systematic review.
BMC Cancer
; 18(1): 696, 2018 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29945565
11.
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.
J Infect Dis
; 216(3): 336-344, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859431
12.
Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.
J Clin Microbiol
; 55(4): 1056-1065, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100595
13.
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.
Prev Med
; 98: 21-30, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27894910
14.
[Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project]. / L'implementazione del DNA-HPV come test primario nei programmi italiani di screening del cervicocarcinoma. Risultati del Progetto MIDDIR.
Epidemiol Prev
; 41(2): 116-124, 2017.
Artículo
en Italiano
| MEDLINE | ID: mdl-28627153
15.
The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments.
Int J Cancer
; 136(12): 2741-51, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740700
16.
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Lancet
; 383(9916): 524-32, 2014 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-24192252
17.
Changes in cervical cancer incidence following the introduction of organized screening in Italy.
Prev Med
; 75: 56-63, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25818232
18.
Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
Epidemiol Prev
; 39(3 Suppl 1): 61-76, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405778
19.
A first survey of HPV-based screening in routine cervical cancer screening in Italy.
Epidemiol Prev
; 39(3 Suppl 1): 77-83, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405779
20.
[Introduction of a centralised system (Service) for collecting clinical data in cancer screening programmes in Piedmont (Northern Italy): a pre-post assessment of a hub&spoke model]. / L'introduzione di un sistema centralizzato (Service) per la raccolta dei dati clinici negli screening oncologici in Piemonte: valutazione pre-post di un modello hub&spoke.
Epidemiol Prev
; 39(4): 243-50, 2015.
Artículo
en Italiano
| MEDLINE | ID: mdl-26499237